Navigation Links
Associated therapy for multiple myeloma

According to a new study it is observed that thalidomide is effective as first-line therapy for newly diagnosed multiple myeloma patients when combined with a standard chemotherapy agent. Researchers from the Mayo Clinic in Rochester, Minn.// gave 60 newly diagnosed myeloma patients the drug thalidomide along with the synthetic steroid dexamethasone. Results show 55 percent of patients responded to the combination. Researchers also observed an improvement in associated symptoms and in disturbances in the blood.

Results also show the thalidomide combination was well tolerated. Researchers say current chemotherapy regimens used as initial therapy for multiple myeloma have significant toxicity. In addition, the thalidomide combination is administered orally while current chemotherapy requires intravenous administration.

Multiple myeloma is a malignant cancer of the plasma cell, which is a type of white blood cell found in many tissues of the body. As the cancer grows, it destroys normal bone tissue, which causes pain and crowds out normal cell production.

Multiple myeloma is the second most common blood cancer in the United States. It remains incurable despite the use of conventional and high dose chemotherapy.


'"/>




Page: 1

Related medicine news :

1. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
2. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
3. Associated scan for detecting ovarian cancer spread
4. Ginseng Associated with Pregnancy Risks
5. Enzyme Associated with Memory
6. 3 die, 500 sickened in nations largest hepatitis A outbreak Associated Press
7. Enzyme Associated With Memory
8. Problems Associated With Iron Deficiency
9. Asbestos Exposure Associated With An Increased Risk For Autoimmune Disease
10. Young Patients On Antidepressants Found To Be Associated With Suicidal Tendencies
11. Sleepiness May Be Associated With Visual Impairment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... August 16, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5 ... , The healthcare industry in the United States has undergone major changes over the ... needing to have a doctor’s order to get a blood test or other lab ...
(Date:8/16/2017)... ... August 16, 2017 , ... Women’s Excellence in ... pain. In addition to oncology services, the new center will specialize in ... heavy bleeding during menstruation), uterine fibroids, and uterine and pelvic adhesions (scar tissue). ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache ...
(Date:8/16/2017)... ... ... Chain”: an inspirational story for those shackled by the chains of a broken life. ... writer and a woman of great faith and wisdom. She is a great motivational ... born and raised in Vero Beach, Florida and has dedicated her life and ministry to ...
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... ... of disease. It’s reaching out to a patient who feels isolated. It’s developing ... amid madness. , WesternU President Daniel R. Wilson, MD, PhD, invited three renowned ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... as president, effective Aug. 7, 2017. ... to pursue other interests and will serve as president emeritus ... has served us in multiple leadership roles since he joined ... 2015 and has provided decisive, strategic leadership which continues to ...
(Date:8/3/2017)... -- Opioid addiction and other drugs of abuse, blood poisoning ... outcomes, were problems taken on directly as laboratory professionals, ... them, met this week. This according to Kalorama Information. ... abuse, procalcitonin and acute kidney injury were key focuses ... in San Diego, CA.  Mechanisms ...
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
Breaking Medicine Technology: